Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis

NCT00450645 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Azienda Ospedaliera Universitaria Policlinico